Physician profile
Christine Dorr
NPI 1871567123
$289.40
in general payments reported to CMS, 2019-2025
10 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.25 · 2022: $21.08 · 2023: $65.41 · 2024: $50.23 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $55.81 | 2024-2025 | Nexplanon |
| Coopersurgical, INC. | $44.34 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $39.13 | 2023-2025 | |
| Exact Sciences Corporation | $25.13 | 2025 | The Cologuard Plus Collection Kit |
| Hologic Sales and Service, LLC | $24.65 | 2025 | Aptima |
| Astellas Pharma US INC | $23.38 | 2023 | Veozah |
| Sage Therapeutics, LLC | $22.82 | 2024 | |
| Therapeuticsmd, INC. | $21.08 | 2022 | |
| Abbvie INC. | $19.25 | 2020 | |
| Millicent US INC | $13.81 | 2025 | Femlyv, Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Dorr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.